GlassScriptPhysician profile
Michael J Rozengarten
NPI 1699764498
$14,346.58
in general payments reported to CMS, 2019-2025
26 companies · $1,911 in 2025
The $1,911 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,706 · 2020: $1,145 · 2021: $1,111 · 2022: $1,614 · 2023: $2,489 · 2024: $3,371 · 2025: $1,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,929 · Travel and Lodging: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,928.61 |
| Travel and Lodging | $842.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,302.68 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Abbott Laboratories | $2,446.29 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Biosense Webster, INC. | $2,392.62 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Biotronik INC. | $2,239.29 | 2020-2025 | Biomonitor, Amvia Edge |
| Medtronic Vascular, INC. | $1,607.41 | 2019 | |
| Medtronic, INC. | $790.24 | 2022-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Sphere-9 |
| Impulse Dynamics (USA) INC. | $254.96 | 2022-2023 | Optimizer |
| Pfizer INC. | $234.13 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $136.03 | 2025 | Wainua |
| Sanofi-Aventis U.S. LLC | $128.52 | 2019-2023 | |
| Amgen INC. | $123.67 | 2019-2023 | Repatha |
| Edwards Lifesciences Corporation | $120.29 | 2020 | |
| Novartis Pharmaceuticals Corporation | $112.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $107.02 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $67.32 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $54.41 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.88 | 2019-2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $30.77 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $30.08 | 2022 | |
| Scpharmaceuticals INC. | $21.07 | 2024 | |
| Esperion Therapeutics, INC. | $18.03 | 2023 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $17.91 | 2024 | |
| Solventum Corporation | $17.16 | 2024 | Prevena |
| Amarin Pharma, INC. | $14.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.70 | 2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $14.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rozengarten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.